Synthon is an international science-centered pharmaceutical company specialized in developing and manufacturing high-quality generic and hybrid medicines. Synthon generates innovative technologies for drug development following all the chain from active pharmaceutical ingredients through to the finished dosage form and is engaged in research in the field of production of pharmaceuticals. Synthon's state-of-the-art, quality products are in demand worldwide and have been tested by patients in many countries and enjoy a high international reputation. Synthon delivers pharmaceutical products to more than 100 countries worldwide.

Synthon Corporation was founded in 1991 in the Netherlands. Its first drug developments were in the field of cardiovascular disease - in 1993 the company launched its first generic dobutamine. Synthon offers a powerful combination of the scientific and human resources for creating affordable medicines. Synthon's philosophy is very much in line with VISTA's values of making modern, quality medicines available to a wide range of people. The head office of the corporation is located in Nijmegen, near Amsterdam in the Netherlands. Synthon drug product manufacturing facilities are located in different countries: active ingredients are manufactured in the Czech Republic and Argentina, finished drug forms are produced in Spain and Chile, research centres for drug development are located in Seoul and Moscow, international registration of products is carried out at one of the subsidiaries in the USA.  

Synthon manufactures many agents for treating oncological diseases for VISTA, such as Pemetrexed-Vista, Everolimus-Vista, Gefitinib-Vista, Abiraterone-Vista and others. These are a wide range of hematological medicines – Bendamustine-Vista, Bortezomib-Vista, Lenalidomide-Vista, Pomalidomide-Vista, drugs given to nephrology patients (Cinacalcet-Vista, Sevelamer-Vista), and drugs given to neurology patients (Glatiramer acetate-Vista, Fingolimod-Vista), drugs to treat osteoporosis (Bonevista) and others. Synthon has been a reliable pharmaceutical partner of VISTA`s for many years.